Announced
Completed
ZQ Capital completed the acquisition of Allergy Therapeutics for £48m.
Synopsis
ZQ Capital, an investment firm, completed the acquisition of Allergy Therapeutics, a specialty pharmaceutical company focused upon the diagnosis and treatment of allergy, for £48m.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite